Trevi Therapeutics (TRVI) News Today → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free TRVI Stock Alerts $3.45 -0.02 (-0.58%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProminent Trevi Italian Restaurant Abruptly Closes at the Forum Shopsmsn.com - March 27 at 1:26 PMTrevi Therapeutics, Inc. (NASDAQ:TRVI) to Post FY2025 Earnings of ($0.60) Per Share, Leerink Partnrs Forecastsamericanbankingnews.com - March 25 at 3:04 AMTrevi Therapeutics (NASDAQ:TRVI) Stock Rating Reaffirmed by Oppenheimeramericanbankingnews.com - March 22 at 7:06 AMTrevi Therapeutics (NASDAQ:TRVI) Stock Rating Reaffirmed by Needham & Company LLCamericanbankingnews.com - March 22 at 6:22 AMTrevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 21 at 11:14 AMOppenheimer Reaffirms "Outperform" Rating for Trevi Therapeutics (NASDAQ:TRVI)marketbeat.com - March 21 at 9:38 AMTrevi Therapeutics, Inc.: Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updatesfinanznachrichten.de - March 21 at 7:22 AMTrevi Therapeutics: Q4 Earnings Insightsbenzinga.com - March 20 at 9:21 PMTRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023msn.com - March 20 at 9:21 PMTrevi Therapeutics Inc (TRVI) Announces Year-End Financials and Progress in Clinical Trialsfinance.yahoo.com - March 20 at 9:21 PMTrevi Therapeutics (TRVI) Set to Announce Earnings on Wednesdayamericanbankingnews.com - March 18 at 1:56 AMGloria Trevi Lights Up New York, Debuts ‘Zorra' Remix With Nebulossamsn.com - March 17 at 10:44 PMGloria Trevi Lights Up New York, Debuts ‘Zorra’ Remix With Nebulossamsn.com - March 16 at 4:38 PMTrevi Therapeutics (TRVI) Set to Announce Quarterly Earnings on Wednesdaymarketbeat.com - March 14 at 3:33 PMTrevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024finance.yahoo.com - March 13 at 8:28 PMOne million Euro gets thrown into Rome’s Trevi Fountain each year. What happens next?msn.com - March 7 at 10:39 AMprivate equity firms who own 35% along with institutions invested in Trevi Therapeutics, Inc. (NASDAQ:TRVI) saw increase in their holdings value last weekfinance.yahoo.com - February 29 at 10:35 AMTrevi Therapeutics to Participate in Upcoming March Eventsfinance.yahoo.com - February 28 at 7:37 AMTrevi Therapeutics to Participate in Upcoming March Eventsprnewswire.com - February 28 at 7:30 AMTrevi Therapeutics Inc.thestreet.com - February 24 at 9:36 AMTRVI Mar 2024 2.000 callfinance.yahoo.com - February 22 at 11:20 PMTRVI Mar 2024 3.000 callfinance.yahoo.com - February 18 at 1:33 PMLeerink Partnrs Analysts Reduce Earnings Estimates for Trevi Therapeutics, Inc. (NASDAQ:TRVI)marketbeat.com - February 8 at 8:13 AMTrevi Therapeutics, Inc. (NASDAQ:TRVI) to Post Q1 2024 Earnings of ($0.09) Per Share, Leerink Partnrs Forecastsmarketbeat.com - February 7 at 8:05 AMTrevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 6 at 10:10 AMTrevi Therapeutics Inc (TRVI)investing.com - January 30 at 3:39 PMMexican popstar Gloria Trevi reflects on career, prison time, new tour: 'It wasn't easy'msn.com - January 22 at 10:45 AMWe're Not Very Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Ratefinance.yahoo.com - January 19 at 2:05 PMTrevi Therapeutics, Inc. (TRVI) Upgraded to Strong Buy: Here's Whyfinance.yahoo.com - January 17 at 2:37 PMTrevi Therapeutics, Inc.: Trevi Therapeutics Provides Business Updatesfinanznachrichten.de - January 4 at 1:29 PMTrevi Therapeutics Provides Business Updatesfinance.yahoo.com - January 4 at 8:29 AMGloria Trevi Sues Former Manager Sergio Andrade Alleging ‘Grotesque Abuse’msn.com - December 29 at 12:19 AMGloria Trevi Sues Her Former Manager and Producer Sergio Andrade for Sexual Abusemsn.com - December 28 at 7:18 PMGloria Trevi Sues Ex-Manager Sergio Andrade With Graphic Claims of Abusemsn.com - December 28 at 7:18 PMGloria Trevi Lawsuit: Judge Dismisses Mary Boquitas’ Defamation Claims Against Jane Doesmsn.com - December 22 at 8:42 PMOppenheimer Reaffirms Their Buy Rating on Trevi Therapeutics (TRVI)markets.businessinsider.com - December 7 at 12:42 AMTrevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)finance.yahoo.com - December 5 at 10:29 AMDown -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)finance.yahoo.com - November 30 at 1:24 PM20 Questions With Gloria Trevi: ‘My Story Is Like Medusa, It Has Always Been Poorly Told’msn.com - November 20 at 8:55 PMAfter Plunging -28.72% in 4 Weeks, Here's Why the Trend Might Reverse for Trevi Therapeutics, Inc. (TRVI)finance.yahoo.com - November 14 at 3:07 PMTrevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?finance.yahoo.com - November 14 at 3:07 PMTrevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 12 at 2:03 PMTrevi Therapeutics, Inc.: Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - November 10 at 5:51 PMTrevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 9 at 9:46 PMTrevi Therapeutics Inc TRVImorningstar.com - November 9 at 6:45 AMTrevi Therapeutics begins trial of chronic cough treatmentmsn.com - November 3 at 4:29 PMTrevi Therapeutics to Report Q3 2023 Financial Results and Provide a Corporate Update on November 9, 2023finance.yahoo.com - November 1 at 5:21 PMPromising Future for Trevi Therapeutics: Buy Rating Justified by Robust Haduvio Data and Expected Developmentsmarkets.businessinsider.com - October 20 at 1:15 PMGloria Trevi Embarks on Mi Soundtrack World Tour Amidst Sexual Assault Allegationsmsn.com - October 12 at 12:17 AMHow to Get Tickets to Gloria Trevi’s “Mi Soundtrack World Tour 2024”yahoo.com - October 12 at 12:17 AM Get Trevi Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… TRVI Media Mentions By Week TRVI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRVI News Sentiment▼0.750.60▲Average Medical News Sentiment TRVI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRVI Articles This Week▼82▲TRVI Articles Average Week Get Trevi Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ME News FGEN News VRCA News ATOS News CRMD News XBIT News GTHX News VNDA News CDT News RIGL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TRVI) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingFed launches fourth dollar overhaulStansberry Research“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.